XML 30 R42.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Iloperidone Sublicense to Novartis Pharma AG (Details Textual) (Novartis [Member]) | 12 Months Ended
--- | ---
Dec. 31, 2013
Minimum [Member] |
Operating Leased Assets [Line Items] |
Percentage of next slab of annual sales for calculating net royalty | 8.00%
Maximum [Member] |
Operating Leased Assets [Line Items] |
Percentage of next slab of annual sales for calculating net royalty | 10.00%

X
- Definition Percentage of next slab of annual sales for calculating net royalty. + References No definition available. + Details
Name: | ttnp_PercentageOfNextSlabOfAnnualSalesForCalculatingNetRoyalty
Namespace Prefix: | ttnp_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_OperatingLeasedAssetsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration